FI62297C - Foerfarande foer framstaellning av 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensotiazin-3-karboxylsyra-1,1-dioxid vilken foereningkan anvaendas saosom mellanprodukt vid framstaellning av taninflammatoriska 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensoti iaz-3-karboxamid-1,1-dioxider - Google Patents

Foerfarande foer framstaellning av 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensotiazin-3-karboxylsyra-1,1-dioxid vilken foereningkan anvaendas saosom mellanprodukt vid framstaellning av taninflammatoriska 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensoti iaz-3-karboxamid-1,1-dioxider Download PDF

Info

Publication number
FI62297C
FI62297C FI771799A FI771799A FI62297C FI 62297 C FI62297 C FI 62297C FI 771799 A FI771799 A FI 771799A FI 771799 A FI771799 A FI 771799A FI 62297 C FI62297 C FI 62297C
Authority
FI
Finland
Prior art keywords
oxo
methyl
dihydro
dioxide
crown
Prior art date
Application number
FI771799A
Other languages
English (en)
Finnish (fi)
Other versions
FI771799A (sv
FI62297B (fi
Inventor
Philip Dietrich Hammen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI771799A publication Critical patent/FI771799A/fi
Publication of FI62297B publication Critical patent/FI62297B/fi
Application granted granted Critical
Publication of FI62297C publication Critical patent/FI62297C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (10)

1. Förfarande för framställning av 3,4-dihydro-2-metyl-4-oxo-2H-1,2-bensotiazin-3-karbonsyra-1,1-dioxid, känne- t e c k n a t därav, att man i närvaro av en källa för hydroxid-joner hydrolyserar en förening med formeln 0 (Oi * 111 I ^ L N CH °2 väri R,j är en alkyl med 1-12 kolatomer eller en fenylalkyl med 1 - 3 kolatomer i alkyldelen, varefter den resulterande produkten görs sur tili ett pH pä ca. 0 - 5,5.
2. Förfarande enligt patentkravet 1,känneteck- n a t därav, att hydrolysen utföres i ett vattenhaltigt lösnings-medelsystem.
3. Förfarande enligt patentkravet 2, känneteck-n a d därav, att hydrolysen utföres vid en temperatur pä ca. 20°C - äterflödestemperaturen för lösningsmedlet.
4. Förfarande enligt patentkravet 3, känneteck-n a t därav, att är alkyl, företrädesvis metyl.
5. Förfarande enligt patentkravet 1, känneteck-n a t därav, att hydrolysen utföres i ett vattenfritt lösnings-medelsystera i närvaro av en kroneter.
6. Förfarande enligt nägot av föregäende patentkravet, kännetecknat därav, att källan för hydroxidjoner är en alkalimetallhydroxid.
7. Förfarande enligt patentkravet 6, kännetecknat därav, att alkalimetallhydroxiden är natriumhydroxid.
8. Förfarande enligt patentkraven 1-5, känne^ t e c k n a t därav, att alkalimetallhydroxiden är kaliumhydr-oxid, det vattenfria lösningsmedlet är bensen eller toluen och kronetern ät 18-kron-6, dicyklohexyl-18-kron-6, dibenso-18-
FI771799A 1976-06-10 1977-06-07 Foerfarande foer framstaellning av 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensotiazin-3-karboxylsyra-1,1-dioxid vilken foereningkan anvaendas saosom mellanprodukt vid framstaellning av taninflammatoriska 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensoti iaz-3-karboxamid-1,1-dioxider FI62297C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/694,572 US4100347A (en) 1976-06-10 1976-06-10 3,4-Dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide
US69457276 1976-06-10

Publications (3)

Publication Number Publication Date
FI771799A FI771799A (sv) 1977-12-11
FI62297B FI62297B (fi) 1982-08-31
FI62297C true FI62297C (fi) 1982-12-10

Family

ID=24789395

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771799A FI62297C (fi) 1976-06-10 1977-06-07 Foerfarande foer framstaellning av 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensotiazin-3-karboxylsyra-1,1-dioxid vilken foereningkan anvaendas saosom mellanprodukt vid framstaellning av taninflammatoriska 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensoti iaz-3-karboxamid-1,1-dioxider

Country Status (37)

Country Link
US (1) US4100347A (sv)
JP (1) JPS5912673B2 (sv)
AR (1) AR215006A1 (sv)
AT (1) AT356126B (sv)
AU (1) AU511643B2 (sv)
BE (1) BE855532A (sv)
BG (1) BG41307A3 (sv)
CA (1) CA1077934A (sv)
CH (1) CH634312A5 (sv)
CS (2) CS191347B2 (sv)
CY (1) CY1128A (sv)
DD (2) DD132014A5 (sv)
DE (1) DE2726175A1 (sv)
DK (1) DK147337C (sv)
EG (1) EG12644A (sv)
ES (2) ES459601A1 (sv)
FI (1) FI62297C (sv)
FR (1) FR2354325A1 (sv)
GB (2) GB1544359A (sv)
GR (1) GR66969B (sv)
HK (2) HK31381A (sv)
HU (1) HU184665B (sv)
IE (1) IE44997B1 (sv)
IL (1) IL52203A (sv)
LU (1) LU77516A1 (sv)
MY (2) MY8100269A (sv)
NL (1) NL7706338A (sv)
NO (1) NO150761C (sv)
NZ (1) NZ184249A (sv)
PH (1) PH14751A (sv)
PL (2) PL108606B1 (sv)
PT (1) PT66639B (sv)
RO (2) RO77179A (sv)
SE (1) SE442200B (sv)
SU (2) SU657747A3 (sv)
YU (1) YU39493B (sv)
ZA (1) ZA773248B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4434164A (en) 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
US4474955A (en) * 1981-06-17 1984-10-02 Vincenzo Iannella Process for preparing 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-[N-(2-pyridinyl)carboxamide]-1,1-dioxide, and its phosphoric ester
IN159273B (sv) * 1981-10-05 1987-04-25 Pfizer
ATE31309T1 (de) * 1982-07-07 1987-12-15 Siegfried Ag Verfahren zur herstellung von 4-hydroxy-2-methyln-2-pyridyl-2h-1,2-benzothiazin-3-carboxamid 1,1- dioxid.
DE3311165A1 (de) * 1983-03-26 1984-09-27 Gödecke AG, 1000 Berlin Feinkristallines isoxicam
IT1194522B (it) * 1983-12-16 1988-09-22 Prodotti Antibiotici Spa Metodo di sintesi di derivanti benzotiazinici
US4530272A (en) * 1984-01-13 1985-07-23 International Business Machines Corporation Method for controlling contamination in a clean room
US5741798A (en) * 1996-06-03 1998-04-21 Boehringer Ingelheim Pharmaceuticals, Inc. 2-benzyl-4-sulfonyl-4H-isoquinolin-1,3-diones and their use as antiinflammatory agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501466A (en) * 1967-11-30 1970-03-17 Mcneilab Inc 3-carbamoyl and 3-alkoxycarbonyl benzothiazine-1,1-dioxides
US3492298A (en) * 1968-02-21 1970-01-27 Mcneilab Inc Oxazino-benzothiazine-6,6-dioxides
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3808205A (en) * 1971-09-10 1974-04-30 Warner Lambert Co Process for the preparation of 4-hydroxy-3-carbamyl-2h-1,2-benzothiazine 1,1-dioxides and 4-hydroxy-3(2h)-1,2-benzothiazine carboxylate-1,1-dioxides
US3853862A (en) * 1973-04-23 1974-12-10 Pfizer Production of 4-hydroxy-1,2-benzothiazine-3-carboxamides
US3892740A (en) * 1974-10-15 1975-07-01 Pfizer Process for the production of carboxamides of oxo-1,2-benzothiazine-1,1-dioxides
US3991584A (en) 1975-01-31 1976-11-16 Western Gear Corporation Shock absorbing and retracting system for pipe laying vessel
US3960856A (en) * 1975-06-20 1976-06-01 Warner-Lambert Company Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide

Also Published As

Publication number Publication date
DE2726175A1 (de) 1977-12-22
SE7706078L (sv) 1977-12-11
BG41307A3 (en) 1987-05-15
GB1544358A (en) 1979-04-19
AR215006A1 (es) 1979-08-31
CY1128A (en) 1982-02-19
IL52203A0 (en) 1977-07-31
YU39493B (en) 1984-12-31
PT66639A (en) 1977-07-01
RO77179A (ro) 1981-06-22
NO150761C (no) 1984-12-12
ES459601A1 (es) 1978-04-01
ZA773248B (en) 1978-04-26
EG12644A (en) 1979-06-30
US4100347A (en) 1978-07-11
IE44997L (en) 1977-12-10
GR66969B (sv) 1981-05-15
DK147337C (da) 1985-01-14
PL108606B1 (en) 1980-04-30
JPS5912673B2 (ja) 1984-03-24
RO70629A (ro) 1981-01-30
PL104307B1 (pl) 1979-08-31
FI771799A (sv) 1977-12-11
DD132014A5 (de) 1978-08-16
FR2354325B1 (sv) 1981-10-30
ATA412177A (de) 1979-09-15
IE44997B1 (en) 1982-06-02
FI62297B (fi) 1982-08-31
NZ184249A (en) 1978-11-13
GB1544359A (en) 1979-04-19
LU77516A1 (sv) 1979-01-19
HU184665B (en) 1984-09-28
ES462973A1 (es) 1978-06-16
NO771870L (no) 1977-12-13
AU2566677A (en) 1978-12-07
PL198768A1 (pl) 1978-04-10
PH14751A (en) 1981-11-20
HK31281A (en) 1981-07-10
NL7706338A (nl) 1977-12-13
CH634312A5 (de) 1983-01-31
JPS52151180A (en) 1977-12-15
MY8100274A (en) 1981-12-31
CS191341B2 (en) 1979-06-29
IL52203A (en) 1979-11-30
DK255577A (da) 1977-12-11
FR2354325A1 (fr) 1978-01-06
AU511643B2 (en) 1980-08-28
SU657747A3 (ru) 1979-04-15
NO150761B (no) 1984-09-03
AT356126B (de) 1980-04-10
YU134877A (en) 1982-08-31
CS191347B2 (en) 1979-06-29
HK31381A (en) 1981-07-10
SE442200B (sv) 1985-12-09
SU833159A3 (ru) 1981-05-23
CA1077934A (en) 1980-05-20
PT66639B (en) 1978-11-09
BE855532A (fr) 1977-12-09
DD137104A5 (de) 1979-08-15
MY8100269A (en) 1981-12-31
DK147337B (da) 1984-06-25

Similar Documents

Publication Publication Date Title
US6001831A (en) Process for producing quinazoline derivatives
US20040167157A1 (en) Process for preparation of amidine derivatives
FI62297C (fi) Foerfarande foer framstaellning av 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensotiazin-3-karboxylsyra-1,1-dioxid vilken foereningkan anvaendas saosom mellanprodukt vid framstaellning av taninflammatoriska 3,4-dihydro-2-metyl-4-oxo-2h-1,2-bensoti iaz-3-karboxamid-1,1-dioxider
NO173016B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-laktamderivater
FI72719B (fi) Syntesfoerfarande foer piroxikam samt mellanprodukt.
PL177317B1 (pl) Nowe kompleksy beta-laktamów i sposób wytwarzania beta-laktamów
Hurd et al. Hydroxamic acids and N-hydroxyimides related to pyridine, pyrazine, and quinoxaline
US5639877A (en) Intermediates in the synthesis of cephalosporins
EP1501838B1 (en) A process for the preparation of clopidogrel
US4988822A (en) Intermediates for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo(1,2-A)pyrrole-1,1-dicarboxylates
CA1063106A (en) Pharmacologically active pyrrolodiazepines
KR810000290B1 (ko) 3, 4-디하이드로-2-메틸-4-옥소-2h-1, 2-벤조티아진-3-카복실산-1, 1-디옥사이드의 제조방법
KR810000291B1 (ko) 3, 4-디하이드로-2-메틸-4-옥소-2h-1, 2-벤조티아진-3-카복실산-1, 1-디옥사이드의 제조방법
US4959495A (en) Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins
US4123611A (en) N-protected amino compounds
US4599406A (en) Process for preparing 2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide derivatives and intermediates therefor
RU2032679C1 (ru) Производные бензатиазинов
US4837317A (en) Process for the preparation of 6-[D(-)alpha-(4-ethyl-2,3-dioxopiperazin-1-ylcarbonylamino)-alpha-phenylacetamido]-penicillanic acid and intermediates useful in this process
EP0198190B1 (en) Compounds having antiplatelet aggregation activity, a process for the preparation thereof and pharmaceutical compositions containing them
NO883219L (no) Framgangsmaate for framstilling av beta-lactam-forbindelse,mellomprodukt for framstilling av denne, og medisinske sammensetninger for behandling av bakteriologiske infeksjonssykdommer inneholdende denne.
FI60017B (fi) Foerfarande foer framstaellning av 6-aminopenicillansyraderivat
US4179557A (en) Acylation of 7-aminocephalosporanic acids
Leskovšek Cizej et al. The synthesis of 3, 4‐dihydro‐2‐methyl‐3‐oxo‐2H‐benzo‐1, 4‐thiazine‐2‐carboxylic acids
KR910003347B1 (ko) 피페리딜 벤즈아미드 유도체의 제조방법
KR870001044B1 (ko) 디히드로-1,4-옥사티인 유도체의 제조방법

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: PFIZER INC.